Abstract:Paromomycin binds specifically to a single type of binding site on the 70-S streptomycin-sensitive Escherichia coli ribosome. This site is different from that of dihydrostreptomycin since paromomycin binds to streptomycin-resistant ribosomes and sine dihydrostreptomycin does not compete for paromomycin binding. Paromomycin binding, unlike dihydrostreptomycin binding, is independent of changes in ribosome concentration but influenced by magnesium ion concentration. Moreover, paromomycin does not bind to the 30-S subunit of the streptomycin-sensitive ribosome, except in the presence of dihydrostreptomycin, which probably induces the conformational changes necessary for a paromomycin binding site. This induction does not occur with streptomycin-resistant ribosomes. Neither antibiotic binds to the 50-S subunit. In general, binding of the one antibiotic increases the number of sites available for binding of the other. Both antibiotics exhibit marked non-specific binding at high antibiotic/ribosome ratios. Competition studies have enabled the classification of other aminoglycosides according to their ability to compete for the paromomycin and dihydrostreptomycin binding sites. Derivatives structurally related to paromomycin compete for its binding, the degree of competition being related to antibacterial activity, but do not compete for dihydrostreptomycin binding; they, on the contrary, increase the number of dihydrostreptomycin binding sites. Neither gentamicin nor kanamycin derivatives, which induce a high level of misreading, nor kasugamycin and spectinomycin, which do not induce misreading, compete for paromomycin or dihydrostreptomycin binding sites. Other sites may be involved in the binding of these aminoglycosides and in inducing misreading.

Aminoglycoside Antibiotics Can Inhibit or Activate Twister Ribozyme Cleavage.

Interaction of Aminoglycosides with Human Mitochondrial 12S Rrna Carrying the Deafness-Associated Mutation

Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate

Modifications of Aminoglycoside Antibiotics Targeting RNA

Modifications Of Aminogocoside Antibiotics Targeting Rna

Distant Ribose 2'-O-Methylation of 23S rRNA Helix 69 Pre-Orders the Capreomycin Drug Binding Pocket at the Ribosome Subunit Interface

Effect of Mutations on Binding of Ligands to Guanine Riboswitch Probed by Free Energy Perturbation and Molecular Dynamics Simulations

Aminoglycoside Mimetics As Small-Molecule Drugs Targeting RNA

[New Inhibitors Targeting Bacterial RNA Polymerase].

Direct testing of natural twister ribozymes from over a thousand organisms reveals a broad tolerance for structural imperfections

Inhibition of Viral Replication by Ribozyme: Mutational Analysis of the Site and Mechanism of Antiviral Activity.

Structural basis for contrasting activities of ribosome binding thiazole antibiotics.

Opportunities for Riboswitch Inhibition by Targeting Co-Transcriptional RNA Folding Events

Atomic-resolution structures of type I ribosome inactivating protein alpha-momorcharin with different substrate analogs

Riboswitch Control Of Induction Of Aminoglycoside Resistance Acetyl And Adenyl-Transferases

Structural analysis of neomycin B and kanamycin A binding Aminoglycosides Modifying Enzymes (AME) and bacterial ribosomal RNA

The Structural Basis for Inhibition of Ribosomal Translocation by Viomycin

Paromomycin and dihydrostreptomycin binding to Escherichia coli ribosomes

Structure-activity relationship of pyrrolidine pentamine derivatives as inhibitors of the aminoglycoside 6'- -acetyltransferase type Ib

Ribosomal RNA methylation and resistance to the antibiotic thiostrepton

An aminoglycoside sensing riboswitch controls the expression of aminoglycoside resistance acetyltransferase and adenyltransferases.